Subcutaneous Biologics Market Growth

The Subcutaneous Biologics Market for approved drugs is anticipated to grow at a CAGR of 5.2% till 2027, further, the subcutaneous formulation technologies market is anticipated to grow at a CAGR of 22.7% | Roots Analysis

According to a recently published report by Roots Analysis, the increasing incidence of chronic diseases and heightened emphasis on patient compliance is driving the subcutaneous biologics market growth

Subcutaneous Biologics Industry Overview

The global subcutaneous biologics market for approved drugs is expected to reach USD 275 billion by 2027, growing at a CAGR of ~5% during the period. Further, the market for formulation technologies is expected to reach over USD 2.5 billion by 2035, growing at a CAGR of ~23% during the forecast period.

Traditionally, biologics were designed for delivery via intravenous route of administration due to their rapid systemic circulation and high bioavailability through this route. Although intravenous administration is an effective method to deliver biologics, it frequently necessitates the need for regular administration by healthcare professionals, creating a challenge in terms of medication adherence. Whereas, subcutaneous biologics can be self-administered at home by the patients themselves, thus reducing their reliance on healthcare facilities and minimizing both cost and time. Additionally, subcutaneous biologics are associated with a lower risk of infusion-related infections, leading to fewer adverse effects. Further, driven by the increasing acceptance and preference of subcutaneous biologics among patients and healthcare professionals, coupled with the ongoing advancements in the field of formulation technologies and drug delivery systems, subcutaneous biologics market is likely to witness substantial growth in the foreseen future.

Browse 385+ figures and 440+ market data tables spread across 780+ pages and detailed Table of Content on “Subcutaneous Biologics Market by Type of Biologic, Type of Therapy, Method of Administration, Fundamental Principle, End User, Payment Method Employed, Therapeutic Area, Drug Delivery Device, Geographical Regions, Leading Players and Sales Forecast: Industry Trends and Global Forecasts, till 2035” here: https://www.rootsanalysis.com/reports/subcutaneous-biologics-delivery/314.html

Market Drivers

Several factors are propelling the subcutaneous biologics market growth. One of the key factors driving the future growth of this market is the growing prevalence of chronic diseases, particularly cancer and diabetes, along with the rising patient preference towards self-injection devices, thus spurring the demand for subcutaneous biologics. Additionally, the growing acceptance of subcutaneous administration among healthcare professionals and patients has led to a shift towards more patient-centric care models, further propelling the market growth. As a result, the market is expected to witness substantial growth in the foreseeable future.

Market Restraints

While the subcutaneous biologics market is experiencing substantial growth, certain factors might hinder its growth. One of the primary restraints is the manufacturing complexities associated with the development of subcutaneous biologics which limits the ability of the drug developers to meet the growing industry demands. In addition, subcutaneous biologics industry is encountering heightened scrutiny and regulatory oversight from government authorities, potentially leading to stricter regulations in the future. This impacts both researchers and drug developers, ultimately causing project setbacks that lead to delay in approvals of drugs and delivery systems.

Growth Factors

Despite the challenges, several growth factors continue to drive the subcutaneous biologics market forward. One notable factor is the ease of administration of subcutaneous biologics at home-care settings, resulting in improved sterility, easy storage and quick delivery of drugs in emergency situations. Moreover, unlike the traditional intravenous drug delivery, subcutaneous administration of drugs has lesser side effects and medication-related errors. Due to these favorable outcomes, there is a heightened demand of subcutaneous biologics for the treatment of chronic diseases.

Subcutaneous Biologics Market Segments

Approved Subcutaneous Biologics Market

Based on the Type of Biologic, the market is segmented into Antibodies, Nucleotides and Proteins

• The antibodies segment led the approved subcutaneous biologics market, capturing the largest revenue share (~60%) in the current year.
• The nucleotides segment is anticipated to grow at an annualized growth rate of 13.1%, during the forecast period.

Based on the Type of Therapy, the market is segmented into Monotherapy, Combination Therapy and Both Monotherapy and Combination Therapy

• The segment for both monotherapy and combination therapy in the subcutaneous biologics market is likely to capture the largest market share of around 50% in the current year.
• The segment for both monotherapy and combination therapy is anticipated to grow at an annualized growth rate of 0.3%, during the forecast period.

Based on the Method of Administration, the market is segmented into Injection, Infusion and Both Injection and Infusion

• The injection segment led the approved subcutaneous biologics market, capturing the largest revenue share (~95%) in the current year.
• The segment for both injection and infusion is anticipated to grow at an annualized growth rate of 4.7%, during the forecast period.

Based on the Therapeutic Area, the market is segmented into Autoimmune Disorders, Metabolic Disorders, Oncological Disorders, Hematological Disorders, Inflammatory Disorders, Neurological Disorders, Bone Disorders and Other Disorders

• The autoimmune disorders segment led the approved subcutaneous biologics market, capturing the largest revenue share (~30%) in the current year.
• The metabolic disorders segment is anticipated to grow at an annualized growth rate of 4.5%, during the forecast period.

Based on the Regional Insights, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America

• North America dominated the approved subcutaneous biologics market and accounted for the largest revenue share (~50%) in the current year.
• In Asia-Pacific, the market is anticipated to show lucrative growth during the forecast period.

Subcutaneous Formulation Technology Market

Based on the Fundamental Principle, the market is segmented into Amino Acid Interaction, Complex Formation, Conjugation, Amino Acid Interaction, Encapsulation and Other Fundamental Principles

• The encapsulation principle segment in the subcutaneous biologics market for formulation technologies is likely to capture the largest market share of around 30% in the current year.
• The amino acid interaction and complex formation principle segments are anticipated to grow at an annualized growth rate of 23.5%, during the forecast period.

Based on the End User, the market is segmented into Biotechnology Companies, Contract Development and Manufacturing Organizations, Educational Institutes, Medical Equipment Manufacturers, MedTech Companies, Pharmaceutical and Biopharmaceutical Companies, and Other End Users

• The pharmaceutical and biopharmaceutical companies segment led the subcutaneous biologics market for formulation technologies, capturing the largest revenue share (65%) in the current year.
• The biotechnology companies segment is anticipated to grow at an annualized growth rate of 24.9%, during the forecast period.

Based on the Therapeutic Area, the market is segmented into Autoimmune Disorders, Bone Diseases, Hematological Disorders, Infectious Diseases, Inflammatory Disorders, Metabolic Disorders, Neurological Disorders, Ocular Disorders, Oncological Disorders and Other Disorders

• The oncological disorders segment in the subcutaneous biologics market for formulation technologies is likely to capture the largest market share of around 20% in the current year.
• The autoimmune disorders segment is anticipated to grow at an annualized growth rate of 23.5%, during the forecast period.

Based on the Regional Insights, the market is segmented into North America, Europe and Asia-Pacific

• North America dominated the subcutaneous biologics market for formulation technologies and accounted for the largest revenue share (~70%) in the current year.
• In Asia-Pacific, the subcutaneous biologics market for formulation technologies is anticipated to demonstrate lucrative growth during the forecast period.

Based on the Payment Method Employed, the market is segmented into Upfront Payments and Milestone Payments

• The milestone payments segment led the subcutaneous biologics market for formulation technologies, capturing the largest revenue share (~50%) in the current year.
• The milestone payments segment is anticipated to grow at an annualized growth rate of 27.6%, during the forecast period.

Companies Profiled

The market report also includes profiles of players (listed below) that are engaged in subcutaneous formulation technology domain:

• Adocia
• Alteogen
• Ascendis Pharma
• CD Bioparticles
• Creative Biolabs
• Creative BioMart
• Foresee Pharmaceuticals
• Pacira Biosciences
• Wyss Institute
• Xeris Biopharma

You Can Download Free Sample PDF Copy of This Report At:

https://www.rootsanalysis.com/reports/subcutaneous-biologics-delivery/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary

Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com